EUROLAB
who-temperature-mapping-and-qualification-of-stability-chambers
Stability Studies (ICH Guidelines) BP Appendix XVI Stability of Finished Products with PreservativesBP Stability Evaluation of Modified Release PreparationsEMA CHMP/QWP/609/2014 Quality Requirements for Stability of BiosimilarsEMA CPMP/QWP/122/02 Stability Testing for Transdermal PatchesEMA Guideline for Stability of Veterinary Medicinal ProductsEMA Guideline on Holding Times for Bulk Products (Stability Implication)EMA Guideline on Stability Testing for Liposomal Drug FormulationsEMA Guideline on Stability Testing for Orally Inhaled ProductsEMA Reflection Paper on Stability for Polymers in Drug DeliveryEMA Reflection Paper on Stability of Advanced Therapies (ATMPs)EMA Stability Testing for Nanoparticle FormulationsEMA Stability Testing in Pediatric FormulationsEMA Stability Testing of Drug-Device Combination ProductsEP 1.2.1 Drug Substance Stability in Multisource SubmissionsEP 2.9.5 Uniformity of Mass Post-Stability TestingEP 3.2.1 Container Closure System Stability EvaluationEP 5.20 Climatic Conditions in Stability Storage ChambersEP 6.0 Stability Testing Requirements for MonographsEP 6.1 Real-Time Stability Testing of Biological ExtractsEP Climatic Zones IVa and IVb for ASEAN and African MarketsFDA 21 CFR 211.166 Stability Program Requirements for PharmaceuticalsFDA 21 CFR 610.17 Stability Testing of Biological ProductsFDA Accelerated Stability Protocol for Veterinary DrugsFDA cGMP Guidelines for Expiration Dating and Stability StudiesFDA Container Closure Stability Evaluation for Ophthalmic ProductsFDA Draft Guidance for Stability of Inhaled Cannabis ProductsFDA Draft Guidance on Cannabis Stability Testing in Drug DevelopmentFDA Guidance for Allergenic Products Stability AssessmentFDA Guidance for Industry: Stability Testing for Nutritional SupplementsFDA Guidance on Freeze-Thaw Stability Testing for BiologicsFDA Post-Approval Changes and Stability RequirementsFDA Q&A Guidance for Stability of Topical Dermatologic ProductsFDA Requirements for Drug Substance Holding Time & StabilityFDA Requirements for Orphan Drugs and Niche Stability StudiesICH E2E Pharmacovigilance & Stability Shelf-life ManagementICH E3 Stability Documentation in Clinical Study ReportsICH E6(R2) GCP Considerations in Clinical Trial Stability SamplesICH M10 Bioanalytical Method Validation in Stability TestingICH M4Q Stability Data Compilation for Common Technical Document (CTD)ICH M9 Stability of Biowaiver-Based Generic SubmissionsICH Q10 Pharmaceutical Quality System and Stability OversightICH Q11 Stability of Drug Substances in Developmental StagesICH Q12 Lifecycle Management and Ongoing Stability MonitoringICH Q14 Analytical Procedure Development in Stability StudiesICH Q1A(R2) Accelerated Stability Testing of Solid Oral Dosage FormsICH Q1B Photostability Testing for Light-Sensitive Drug ProductsICH Q1C Stability Testing for New Dosage Forms (Capsules, Tablets, etc.)ICH Q1D Bracketing and Matrixing Design Stability Protocol DevelopmentICH Q1E Evaluation of Stability Data for Regulatory SubmissionsICH Q1F Stability Data Requirements for Global RegistrationICH Q2(R1) Validation of Analytical Procedures in Stability StudiesICH Q3B(R2) Stability Testing of Impurities in Drug ProductsICH Q3C Residual Solvent Stability in Finished Dosage FormsICH Q4 Guidelines for Pharmacopoeial Stability HarmonizationICH Q4B Annex Stability-Related Harmonization for Global FilingICH Q5C Stability Testing of Biotechnological/Biological ProductsICH Q5D Derivation and Stability of Cell SubstratesICH Q6B Specifications Testing for Biotech Products in Long-Term StudiesICH Q8 Design Space for Stability-Critical ParametersICH Q9 Risk-Based Stability Planning and Protocol DesignICH S3B Photostability of Biologics in Animal StudiesICH S4 Stability of New Veterinary Drug Substances and ProductsICH S6(R1) Preclinical Stability of Biotech ProductsISO 10993-1 Biocompatibility Stability Studies in Medical DevicesISO 11607 Package Integrity Stability for Sterile Medical DevicesISO 13408 Stability Testing of Aseptic Processing SystemsISO 14644 Environmental Monitoring for Stability ChambersISO 14971 Risk Management Related to Stability FailuresISO 15378 GMP for Primary Packaging Stability InteractionsISO 17025 Stability Testing Accreditation RequirementsISO 17034 Reference Material Stability and HomogeneityISO 20387 Stability Assessment in Biobanking Sample StorageISO 21973 Transport Stability of Cell-Based TherapiesISO 9001:2015 Quality System Requirements for Stability ProgramsUSP <1046> Cellular and Gene Therapy Product StabilityUSP <1049> Excipient Stability and Shelf-Life EvaluationUSP <1079> Storage and Stability Testing in Distribution SystemsUSP <1086> Impurities Testing within Stability ProtocolsUSP <1090> Assessment of Drug Product Performance Post StabilityUSP <1118> Monitoring Stability in Storage and Transport ConditionsUSP <1168> Stability Testing for RadiopharmaceuticalsUSP <1191> Stability Considerations in Compounding Pharmacy ProductsUSP <1224> Transfer of Analytical Procedures in Stability StudiesUSP <1225> Validation of Compendial Procedures in Stability ContextUSP <1226> Verification of Compendial Procedures Post-StabilityUSP <671> Stability Testing of Packaging MaterialsUSP <795> Stability Evaluation of Nonsterile PreparationsUSP <797> Stability Testing of Sterile Preparations in CleanroomsWHO Annex 10 Stability Testing of Active Pharmaceutical IngredientsWHO Annex 7 Stability of Reconstituted Lyophilized ProductsWHO Annex 9 Stability for Zoonotic Biological ProductsWHO Good Storage and Distribution Practices for StabilityWHO Guidelines for Stability of DNA and mRNA VaccinesWHO Guidelines on Stability of Combination ARV TherapiesWHO Stability of Monoclonal Antibodies Under Accelerated ConditionsWHO Stability Requirements for Medical Oxygen and InhalersWHO Stability Testing for Pre-Filled Syringes and Auto-InjectorsWHO TRS 1003 Stability Protocols for Combination ProductsWHO TRS 1010 Stability Testing for Vaccines under Cold Chain ConditionsWHO TRS 1019 Stability Testing of Blood and Blood ProductsWHO TRS 953 Climatic Zone-Based Stability Testing for Global MarketsWHO TRS 970 Real-Time Stability Assessment for WHO PrequalificationWHO TRS 992 Long-Term Stability Testing for Herbal Medicinal Products

WHO Temperature Mapping and Qualification of Stability Chambers Laboratory Testing Service: A Comprehensive Guide

The World Health Organization (WHO) recommends the use of temperature mapping and qualification of stability chambers for the validation of pharmaceutical and biopharmaceutical products. This testing service is governed by several international and national standards, including ISO 80005-1:2012(E), ISO 80005-3:2014(E), ASTM E1615-17, EN ISO 11382:2009, and TSE EN ISO 80005-1.

These standards provide guidelines for the design, installation, and qualification of temperature mapping and stability chambers. They also outline the requirements for testing equipment, calibration procedures, and data analysis methods.

Standard Development Organizations

The standard development organizations responsible for these standards include:

  • International Organization for Standardization (ISO)
  • American Society for Testing and Materials (ASTM)
  • European Committee for Standardization (CEN)
  • Turkish Standards Institution (TSE)
  • These organizations work together to develop, maintain, and update international and national standards.

    Standard Evolution and Updates

    Standards evolve over time as new technologies and testing methods become available. The standard development process involves a thorough review of existing standards, identification of areas for improvement, and the development of new standards or updates to existing ones.

    Specific Standard Numbers and Scope

    The following are some specific standard numbers and their scope:

  • ISO 80005-1:2012(E) - Design, installation, and qualification of temperature mapping and stability chambers
  • ASTM E1615-17 - Validation of temperature mapping and stability chambers
  • EN ISO 11382:2009 - Temperature mapping and qualification of stability chambers
  • Standard Compliance Requirements

    Compliance with these standards is mandatory for pharmaceutical and biopharmaceutical companies. Non-compliance can result in regulatory issues, product recalls, and financial penalties.

    Industry-Specific Examples and Case Studies

    The following are some industry-specific examples and case studies:

  • A pharmaceutical company conducts a temperature mapping study to ensure that its stability chambers meet the required standards.
  • A biotechnology company validates its temperature mapping and qualification of stability chambers using ISO 80005-1:2012(E).
  • The WHO temperature mapping and qualification of stability chambers testing service is essential for ensuring product safety, reliability, and compliance with regulatory requirements.

    Why This Test Is Needed

    This test is needed to:

  • Ensure that temperature mapping and stability chambers meet the required standards
  • Validate the performance of temperature mapping and stability chambers
  • Identify areas for improvement in temperature mapping and stability chamber design and operation
  • Consequences of Not Performing This Test

    Non-compliance with these standards can result in:

  • Regulatory issues and penalties
  • Product recalls and financial losses
  • Damage to reputation and brand image
  • Industries and Sectors That Require This Testing

    The following industries and sectors require this testing:

  • Pharmaceutical companies
  • Biotechnology companies
  • Medical device manufacturers
  • Food industry companies
  • Quality Assurance and Quality Control Aspects

    This test contributes to product safety, reliability, and compliance with regulatory requirements. It also helps to:

  • Ensure that products are manufactured consistently and meet the required standards
  • Identify areas for improvement in temperature mapping and stability chamber design and operation
  • Validate the performance of temperature mapping and stability chambers
  • Risk Factors and Safety Implications

    This test helps to identify potential risks and safety implications associated with temperature mapping and stability chamber design and operation. It also helps to:

  • Ensure that products are manufactured safely and meet regulatory requirements
  • Identify areas for improvement in temperature mapping and stability chamber design and operation
  • Validate the performance of temperature mapping and stability chambers
  • Competitive Advantages

    This test provides a competitive advantage by:

  • Ensuring compliance with regulatory requirements
  • Validating product safety and reliability
  • Identifying areas for improvement in temperature mapping and stability chamber design and operation
  • Cost-Benefit Analysis

    The cost-benefit analysis of this testing service is as follows:

  • Benefits: Improved product safety, reliability, and compliance with regulatory requirements; reduced risk of regulatory issues and penalties; improved brand image and reputation.
  • Costs: Investment in equipment, personnel, and training.
  • The WHO temperature mapping and qualification of stability chambers testing service involves the following steps:

    1. Sample Preparation

    Prepare samples for testing by ensuring they are representative of the product and meet the required standards.

    2. Testing Equipment and Instruments

    Use calibrated testing equipment and instruments, including thermometers, hygrometers, and pressure gauges.

    3. Temperature Mapping Study

    Conduct a temperature mapping study to ensure that the stability chambers meet the required standards.

    4. Qualification of Stability Chambers

    Qualify the stability chambers using ISO 80005-1:2012(E) or ASTM E1615-17.

    The WHO temperature mapping and qualification of stability chambers testing service involves the following steps:

    1. Data Analysis

    Analyze data from the temperature mapping study and qualification of stability chambers.

    2. Reporting

    Prepare a report detailing the findings of the temperature mapping study and qualification of stability chambers.

    3. Documentation

    Maintain documentation of the testing process, including test results, calibration records, and equipment maintenance.

    Why Choose Our Laboratory Testing Service?

    Our laboratory testing service offers the following benefits:

  • Expertise in WHO temperature mapping and qualification of stability chambers testing
  • State-of-the-art equipment and facilities
  • Fast turnaround times and competitive pricing
  • Conclusion

    The WHO temperature mapping and qualification of stability chambers testing service is essential for ensuring product safety, reliability, and compliance with regulatory requirements. Our laboratory testing service offers the expertise, equipment, and facilities needed to conduct this testing.

    References

  • ISO 80005-1:2012(E) - Design, installation, and qualification of temperature mapping and stability chambers
  • ASTM E1615-17 - Validation of temperature mapping and stability chambers
  • EN ISO 11382:2009 - Temperature mapping and qualification of stability chambers
  • We hope this comprehensive guide has provided valuable information on the WHO temperature mapping and qualification of stability chambers testing service. If you have any further questions or would like to discuss your testing needs, please do not hesitate to contact us.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers